The Dallas Hereditary Spherocytosis Cohort Study
NCT01141621 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2013-05-14
Summary
The purpose of this study is to
1. better characterize the short term and long term natural history of hereditary spherocytosis (HS) including diagnosis, complications, and indications for and response to splenectomy
2. evaluate and describe the health-related quality of life in children with HS.
Conditions
- Hereditary Spherocytosis
Sponsors & Collaborators
-
University of Texas Southwestern Medical Center
lead OTHER
Eligibility
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2013-05-31
- Completion
- 2013-05-31
More Related Trials
-
Study of Blood Platelets in Sickle Cell Disease
NCT00226083 ·Status: WITHDRAWN
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension
NCT00850369 ·Status: WITHDRAWN ·Phase: PHASE2
-
Social Media Use in Sickle Cell Patients
NCT05182216 ·Status: WITHDRAWN
-
Dasatinib in Polycythemia Vera
NCT00538980 ·Status: TERMINATED ·Phase: PHASE2
-
Haploidentical Hematopoietic Stem Cell Transplantation
NCT02165007 ·Status: COMPLETED ·Phase: PHASE1
-
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
NCT00993694 ·Status: COMPLETED
-
Obesity in Pediatric Sickle Cell Disease: A New Phenomenon
NCT04676113 ·Status: COMPLETED
-
Hematological Anomalies in Children With Rasopathy
NCT04286360 ·Status: RECRUITING
-
Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease
NCT05012631 ·Status: RECRUITING ·Phase: PHASE2
-
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
NCT01419704 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease
NCT04594031 ·Status: WITHDRAWN ·Phase: PHASE1
-
CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease
NCT04091737 ·Status: TERMINATED ·Phase: PHASE1
-
the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia
NCT05864170 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
NCT00661804 ·Status: COMPLETED
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
Long Term Outcomes in β Thalassemia Major
NCT02307786 ·Status: COMPLETED
-
Prognostic Factors of Acute Splenic Sequestration
NCT01207037 ·Status: COMPLETED ·Phase: NA
-
The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
NCT00230165 ·Status: RECRUITING
-
Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell Center
NCT00005327 ·Status: COMPLETED
-
Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrome
NCT01410825 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)
NCT00528203 ·Status: TERMINATED
-
Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
NCT00011648 ·Status: COMPLETED
-
Iron Overload and Transient Elastography in Patients With Myelodysplastic Syndrome
NCT02262312 ·Status: COMPLETED
-
Genomic Screening for Hereditary Erythrocytosis and Related Diseases
NCT03263364 ·Status: UNKNOWN